2016/11/15 Reven News Press

The Reven team is proud to announce their latest US patent allowance, titled “Methods of Treating or Ameliorating Diseases and Enhancing Performance Comprising the use of a Magnetic Dipole Stabilized Solution”. This patent gives us the future opportunity to expand beyond cardiovascular disease while strongly protecting our research and development on many medical conditions such as cancer, inflammation and neurodegenerative disease.